BOEHRINGER Ingelheim's anticoagulation reversal agent Praxbind has demonstrated "rapid, complete, and sustained reversal of dabigatran etexilate" (Pradaxa) in a new study dubbed RE-VERSE AD.
Median time to homeostasis was 2.5 hours - CLICK HERE for the study.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jul 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jul 17